The 2016-2017 Federal Budget confirms that the Pharmaceutical Benefits Scheme is stable and will continue to ensure Australian patients have access to safe, effective medicines following years of significant reforms in the sector. The shared hard work of industry and successive governments to implement reforms to the PBS since 2007 has made a … [Read more...]
Medicines sector reforms deliver consumer benefits and a sustainable PBS
Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April. The direct contribution the medicine supply chain is making to these savings will ensure the PBS is sustainable into the future, enabling the reinvestment savings into the funding of new, breakthrough … [Read more...]
PBS per capita spending at 10 year low
The sustainability of the Pharmaceutical Benefits Scheme has been highlighted by the release of Productivity Commission data which puts the cost of the PBS per person at a 10 year low. The Productivity Commission Report on Government Services is the latest confirmation of the clear trend of declining growth and spending on the PBS in recent … [Read more...]